HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John Termini Selected Research

corrole

1/2020Protein-coated corrole nanoparticles for the treatment of prostate cancer cells.
1/2019Cell-Penetrating Protein/Corrole Nanoparticles.
11/2014A cytotoxic and cytostatic gold(III) corrole.
2/2012Differential cytostatic and cytotoxic action of Metallocorroles against human cancer cells: potential platforms for anticancer drug development.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John Termini Research Topics

Disease

13Neoplasms (Cancer)
01/2020 - 12/2003
2Prostatic Neoplasms (Prostate Cancer)
01/2020 - 01/2019
2Brain Neoplasms (Brain Tumor)
01/2018 - 01/2014
2Melanoma (Melanoma, Malignant)
04/2016 - 02/2012
2Breast Neoplasms (Breast Cancer)
01/2014 - 02/2012
2Metabolic Diseases (Metabolic Disease)
03/2011 - 03/2010
1Parkinson Disease (Parkinson's Disease)
01/2022
1Mitochondrial Diseases (Mitochondrial Disease)
01/2022
1Hypoxia (Hypoxemia)
10/2021
1Genomic Instability
10/2021
1Rupture
01/2020
1Disease Progression
01/2020
1Necrosis
01/2020
1Colonic Neoplasms (Colon Cancer)
07/2019
1Glioma (Gliomas)
01/2018
1Glioblastoma (Glioblastoma Multiforme)
01/2018
1Hyperglycemia
01/2017
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2017
1Type 2 Diabetes Mellitus (MODY)
01/2017
1Neoplasm Metastasis (Metastasis)
01/2014
1Seizures (Absence Seizure)
04/2013
1Epilepsy (Aura)
04/2013
1Obesity
03/2010
1HIV Infections (HIV Infection)
05/2005
1Virus Diseases (Viral Diseases)
05/2005
1Communicable Diseases (Infectious Diseases)
05/2005
1Carcinogenesis
12/2004

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
01/2022 - 03/2010
5DNA (Deoxyribonucleic Acid)IBA
01/2018 - 12/2004
4corroleIBA
01/2020 - 02/2012
3Glucose (Dextrose)FDA LinkGeneric
10/2021 - 03/2010
3Pharmaceutical PreparationsIBA
01/2020 - 02/2012
3GalliumIBA
01/2019 - 02/2012
3Advanced Glycation End ProductsIBA
01/2018 - 03/2010
2Pyruvaldehyde (Methylglyoxal)IBA
01/2018 - 03/2011
2LipidsIBA
01/2017 - 03/2010
2AldehydesIBA
03/2011 - 12/2004
1Prolyl Hydroxylases (Prolyl Hydroxylase)IBA
10/2021
1Antineoplastic Agents (Antineoplastics)IBA
01/2020
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2020
1Human Serum AlbuminFDA LinkGeneric
01/2020
1CalciumIBA
01/2020
1Glycoproteins (Glycoprotein)IBA
07/2019
1DesmocollinsIBA
07/2019
1Small Interfering RNA (siRNA)IBA
01/2018
1Biomarkers (Surrogate Marker)IBA
01/2017
1Carboxylic AcidsIBA
04/2016
1tris(pentafluorophenyl)corroleIBA
04/2016
1Lanthanoid Series Elements (Lanthanides)IBA
01/2016
1Cisplatin (Platino)FDA LinkGeneric
11/2014
1GoldIBA
11/2014
1Succinic Acid (Succinate)IBA
01/2014
1ParvalbuminsIBA
01/2014
1NAD (NADH)IBA
01/2014
1GABA Plasma Membrane Transport ProteinsIBA
01/2014
1Transaminases (Aminotransferases)IBA
01/2014
1gamma-Aminobutyric Acid (GABA)IBA
01/2014
1GABA Receptors (GABA Receptor)IBA
01/2014
1PicrotoxinIBA
04/2013
1EnzymesIBA
04/2013
1Biological ProductsIBA
04/2013
1Pilocarpine (Ocusert)FDA LinkGeneric
04/2013
1MetalsIBA
02/2012
1Cytostatic AgentsIBA
02/2012
1Biopolymers (Biopolymer)IBA
03/2011
1EpitopesIBA
05/2005
1VaccinesIBA
05/2005
1Peptides (Polypeptides)IBA
05/2005
1perhydroxyl radicalIBA
12/2004
1Fatty Acids (Saturated Fatty Acids)IBA
12/2003

Therapy/Procedure

4Therapeutics
10/2017 - 08/2014